NEW YORK – Dermatology genomics testing company DermTech said on Thursday that Medicare Administrative Contractor Palmetto GBA MolDx has issued a final local coverage determination for the company's Pigmented Lesion Assay (PLA).
NEW YORK – Dermatology genomics testing company DermTech said on Thursday that Medicare Administrative Contractor Palmetto GBA MolDx has issued a final local coverage determination for the company's Pigmented Lesion Assay (PLA).
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.